Jason Kelly, Ginkgo CEO (Kyle Grillot/Bloomberg via Getty Images)

At­ten­tion biotech his­to­ry: Gink­go pours $700M+ on just 2 ex­ecs

Gink­go CEO Ja­son Kel­ly and COO Resh­ma Shet­ty just be­came two of the most high­ly paid ex­ec­u­tives in biotech his­to­ry — sort of.

The con­tro­ver­sial syn­thet­ic bi­ol­o­gy com­pa­ny, sub­ject to near­ly a year of scruti­ny from jour­nal­ists and short-sell­ers af­ter a SPAC that val­ued it at $15 bil­lion, re­leased an an­nu­al re­port Wednes­day that in­clud­ed the an­nu­al com­pen­sa­tion for the two founder-ex­ec­u­tives: $364 mil­lion, apiece.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.


Alexandria Real Estate Equities

Cambridge, MA, USA